CaMKII, endocannabinoids, synaptic plasticity and motor function
CaMKII、内源性大麻素、突触可塑性和运动功能
基本信息
- 批准号:9102281
- 负责人:
- 金额:$ 38.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:2-arachidonylglycerolAtaxiaBasal GangliaBehaviorBindingBiological AssayBrainBrain regionCa(2+)-Calmodulin Dependent Protein KinaseCalcium/calmodulin-dependent protein kinaseCellsCerebellumComplexCorpus striatum structureDepressed moodDopamineDopamine D2 ReceptorElectrophysiology (science)EndocannabinoidsEnzymesEquilibriumExcitatory SynapseExhibitsFollow-Up StudiesFunctional disorderGlutamatesGoalsHealthHippocampus (Brain)Home environmentHuntington DiseaseHyperactive behaviorKnock-inKnock-in MouseLearningLinkMemoryMetabolismMolecularMonitorMotorMotor ActivityMotor CortexMovementMovement DisordersMusMutant Strains MiceMutationNeuronsOutputParkinson DiseasePathway interactionsPeptidesPhosphorylationPhosphorylation SitePhysiologicalPlayPropertyProteinsRegulationReporterRoleSignal TransductionSiteSliceSynapsesSynaptic plasticityTestingThalamic structureTracerTransgenic Organismsbasecalmodulin-dependent protein kinase IIendocannabinoid signalinggamma-Aminobutyric Acidin vivoinhibitor/antagonistlipoprotein lipasemotor deficitmotor learningnervous system disordernew therapeutic targetnovelpostsynapticselective expressionsynaptic depressionsynaptic functiontool
项目摘要
DESCRIPTION (provided by applicant): The striatum plays a key role in motor activity/coordination and goal-directed, habitual learning. Normal striatal drive of motor activity
requires precisely balanced opposing outputs from two types of striatal medium spiny neurons (MSNs) that express D1- and D2-dopamine(DA) receptors. A complex signaling cross-talk between glutamate and DA in D1- and D2-MSNs involves "on demand" Ca2+-dependent endocannabinoid (eCB) synthesis. Thus, DA, glutamate and eCBs collaborate to balance short- and long-term control of the two striatal output pathways by engaging distinct signaling mechanisms in the two MSN subtypes. Disruption of these mechanisms can induce motor deficits (e.g., Parkinson's Disease) or other abnormal striatal-based behaviors. Ca2+/calmodulin-dependent protein kinase II (CaMKII) has diverse bidirectional roles controlling excitatory synapses in hippocampus, cortex and cerebellum. While CaMKII is expressed in both striatal MSN subtypes, suggesting that it regulates excitatory inputs to striatal MSNs and motor activity, the precise functions of striatal CaMKII are poorly understood. Our analyses of knockin mutant mice with the Thr286 autophosphorylation site in CaMKIIα replaced by Ala (T286A-KI mice) revealed specific roles for CaMKII in long- and short term eCB- dependent control of excitatory inputs to D1- and D2-MSNs. We also found that CaMKIIα associates with and phosphorylates diacylglycerol lipase α (DGLα), the rate-limiting enzyme for Ca2+-dependent synthesis of the most abundant brain eCB, 2-arachidonyl glycerol (2-AG). In addition, baseline hyperactivity of T286A-KI mice can be rescued by inhibiting 2-AG breakdown. These initial findings strongly support a novel hypothesis that CaMKII is a critical link between postsynaptic Ca2+ and the initiation of 2-AG signaling that controls striatal synapses and striatal based-behaviors. We also created novel transgenic eAC3I mice that selectively express a short CaMKII inhibitor peptide fused to eGFP in striatal MSNs. Three specific aims will exploit unique features of T286A-KI and eAC3I mice to test specific hypotheses about the roles of striatal CaMKII autophosphorylation and activity. 1. Test the hypothesis that Ca2+-dependent 2-AG synthesis is modulated by CaMKII. We will identify sites of phosphorylation and CaMKII-binding domains in DGLα. DGLα phosphorylation, DGLα activity and 2-AG synthesis will be investigated in heterologous cells and in striatal slices from WT, T286A-KI and eAC3I mice. 2. Test the hypothesis that CaMKII modulates eCB-dependent synaptic regulation in striatal MSNs. Short and long-term roles of CaMKII will be determined by comparing the properties of excitatory synaptic inputs to D1- and D2-MSNs in striatal slices from WT, T286A-KI and eAC3I mice, and by using CaMKII inhibitor peptides. 3. Test the hypothesis that CaMKII modulates eCB-dependent motor activity. We will evaluate motor activity and coordination under basal conditions and following pharmacological modulation of 2-AG metabolism in WT, T286A-KI and eAC3I mice.
描述(由申请人提供):纹状体在运动活动/协调和目标导向的习惯性学习中发挥着关键作用。运动活动的正常纹状体驱动
需要来自表达 D1 和 D2 多巴胺 (DA) 受体的两种纹状体中型多巴胺神经元 (MSN) 的精确平衡的相反输出。 D1-和 D2-MSN 中谷氨酸和 DA 之间复杂的信号串扰涉及“按需”Ca2+ 依赖性内源性大麻素 (eCB) 合成。因此,DA、谷氨酸和 eCB 通过参与两种 MSN 亚型中不同的信号传导机制,协作平衡两种纹状体输出途径的短期和长期控制。这些机制的破坏可能会导致运动缺陷(例如帕金森病)或其他基于纹状体的异常行为。 Ca2+/钙调蛋白依赖性蛋白激酶 II (CaMKII) 具有多种双向作用,控制海马、皮质和小脑的兴奋性突触。虽然 CaMKII 在两种纹状体 MSN 亚型中都有表达,表明它调节纹状体 MSN 的兴奋性输入和运动活动,但纹状体 CaMKII 的精确功能尚不清楚。我们对 CaMKIIα 中 Thr286 自磷酸化位点被 Ala 取代的敲入突变小鼠(T286A-KI 小鼠)的分析揭示了 CaMKII 在 D1- 和 D2-MSN 兴奋性输入的长期和短期 eCB 依赖性控制中的特定作用。我们还发现 CaMKIIα 与二酰基甘油脂肪酶 α (DGLα) 结合并磷酸化,DGLα 是最丰富的脑 eCB、2-花生四烯酰甘油 (2-AG) 的 Ca2+ 依赖性合成的限速酶。此外,T286A-KI 小鼠的基线过度活跃可以通过抑制 2-AG 分解来挽救。这些初步发现有力地支持了一个新的假设,即 CaMKII 是突触后 Ca2+ 和控制纹状体突触和纹状体行为的 2-AG 信号传导启动之间的关键联系。我们还创建了新型转基因 eAC3I 小鼠,其在纹状体 MSN 中选择性表达与 eGFP 融合的短 CaMKII 抑制肽。三个具体目标将利用 T286A-KI 和 eAC3I 小鼠的独特特征来测试有关纹状体 CaMKII 自磷酸化和活性的作用的具体假设。 1. 检验 Ca2+ 依赖性 2-AG 合成受 CaMKII 调节的假设。我们将鉴定 DGLα 中的磷酸化位点和 CaMKII 结合域。将在异源细胞和 WT、T286A-KI 和 eAC3I 小鼠的纹状体切片中研究 DGLα 磷酸化、DGLα 活性和 2-AG 合成。 2. 检验 CaMKII 调节纹状体 MSN 中 eCB 依赖性突触调节的假设。 CaMKII 的短期和长期作用将通过比较 WT、T286A-KI 和 eAC3I 小鼠纹状体切片中 D1-和 D2-MSN 的兴奋性突触输入的特性并使用 CaMKII 抑制剂肽来确定。 3. 检验 CaMKII 调节 eCB 依赖性运动活动的假设。我们将评估 WT、T286A-KI 和 eAC3I 小鼠在基础条件下以及 2-AG 代谢的药理调节后的运动活动和协调性。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROGER J COLBRAN其他文献
ROGER J COLBRAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROGER J COLBRAN', 18)}}的其他基金
Molecular Neuropharmacology and Signaling of Histone H2A.Z
组蛋白 H2A.Z 的分子神经药理学和信号转导
- 批准号:
9626431 - 财政年份:2017
- 资助金额:
$ 38.25万 - 项目类别:
Molecular Neuropharmacology and Signaling of Histone H2A.Z
组蛋白 H2A.Z 的分子神经药理学和信号转导
- 批准号:
9480880 - 财政年份:2017
- 资助金额:
$ 38.25万 - 项目类别:
Molecular Neuropharmacology and Signaling of Histone H2A.Z
组蛋白 H2A.Z 的分子神经药理学和信号转导
- 批准号:
10115117 - 财政年份:2017
- 资助金额:
$ 38.25万 - 项目类别:
Postdoctoral Program in Functional Neurogenomics
功能神经基因组学博士后项目
- 批准号:
9386221 - 财政年份:2016
- 资助金额:
$ 38.25万 - 项目类别:
CaMKII, endocannabinoids, synaptic plasticity and motor function
CaMKII、内源性大麻素、突触可塑性和运动功能
- 批准号:
8536971 - 财政年份:2012
- 资助金额:
$ 38.25万 - 项目类别:
CaMKII, endocannabinoids, synaptic plasticity and motor function
CaMKII、内源性大麻素、突触可塑性和运动功能
- 批准号:
8885927 - 财政年份:2012
- 资助金额:
$ 38.25万 - 项目类别:
CaMKII, endocannabinoids, synaptic plasticity and motor function
CaMKII、内源性大麻素、突触可塑性和运动功能
- 批准号:
8697154 - 财政年份:2012
- 资助金额:
$ 38.25万 - 项目类别:
CaMKII, endocannabinoids, synaptic plasticity and motor function
CaMKII、内源性大麻素、突触可塑性和运动功能
- 批准号:
8438247 - 财政年份:2012
- 资助金额:
$ 38.25万 - 项目类别:
Postdoctoral Program in Functional Neurogenomics
功能神经基因组学博士后项目
- 批准号:
9925810 - 财政年份:2002
- 资助金额:
$ 38.25万 - 项目类别:
Postdoctoral Program in Functional Neurogenomics
功能神经基因组学博士后项目
- 批准号:
9096901 - 财政年份:2002
- 资助金额:
$ 38.25万 - 项目类别:
相似海外基金
How exercise improves ataxia in SCA6
运动如何改善 SCA6 的共济失调
- 批准号:
479005 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
Operating Grants
Exploratoin of Nrf2 activators that potentiate chaperone-mediated autophagy and are useful for the treatment of spinocrebellar ataxia
探索增强伴侣介导的自噬并可用于治疗脊髓小脑共济失调的 Nrf2 激活剂
- 批准号:
23K06161 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia
定义 Tox3 在先天性小脑发育不全和共济失调中的作用
- 批准号:
10799992 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
Genome-wide dysregulation of R-loops in Ataxia Telangiectasia neurological pathogenesis
共济失调毛细血管扩张症神经发病机制中 R 环的全基因组失调
- 批准号:
10607414 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
Identifying the molecular mechanisms of GEMIN5 mutations in a novel cerebellar ataxia syndrome
鉴定新型小脑共济失调综合征中 GEMIN5 突变的分子机制
- 批准号:
10753403 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
Project 2: Therapeutic Gene Editing for Friedreich's Ataxia
项目 2:弗里德赖希共济失调的治疗性基因编辑
- 批准号:
10668768 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
The Impact of Vitamin D on mTOR Signaling, Seizures, and Motor Behavior in a Mouse Model of Hyperactive mTOR Induced Epilepsy and Ataxia
维生素 D 对 mTOR 过度活跃诱发癫痫和共济失调小鼠模型中 mTOR 信号传导、癫痫发作和运动行为的影响
- 批准号:
10754319 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
Pathological Mechanisms of Immune-Mediated Cerebellar Ataxia with Associated Sez6L2 Autoantibodies
免疫介导的小脑共济失调与相关 Sez6L2 自身抗体的病理机制
- 批准号:
10740682 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别:
Molecular Pathogenesis of spinocerebellar ataxia type 12
12 型脊髓小脑共济失调的分子发病机制
- 批准号:
10579736 - 财政年份:2023
- 资助金额:
$ 38.25万 - 项目类别: